Evaluation of ceramics composed of different hydroxyapatite to tricalcium phosphate ratios as carriers for rhBMP-2

Imranul Alam, Izumi Asahina, Kohichi Ohmamiuda, Kouichiro Takahashi, Shoji Yokota, Shoji Enomoto

Research output: Contribution to journalArticle

110 Citations (Scopus)

Abstract

We have investigated pellet-shaped implants prepared from biphasic calcium phosphate (BCP) ceramics with five different ratios of hydroxyapatite (HAP) to beta tricalcium phosphate (β-TCP). The purpose of this study was to evaluate these BCP ceramics as carriers for rhBMP-2. BCP ceramics impregnated with the different doses of recombinant human bone morphogenetic protein 2 (rhBMP-2) (1, 5 and 10μg) were used for the experimental purpose and the ceramics without rhBMP-2 were used as control. The pellets were placed into subcutaneous pockets on the dorsum of 4-week-old male Wistar rats. The animals were sacrificed 2 and 4 weeks after implantation. Bone induction was estimated by alkaline phosphatase (ALP) activity measured at 2 weeks after implantation. Pellets were also examined radiologically, histologically and histomorphometrically. The results showed that all experimental pellets exhibited new bone formation whereas the control pellets produced only fibrous connective tissue. Here, 100% HAP ceramic showed most amount of bone formation, whereas 25% HAP to 75% TCP ceramic produced the bone least in amount among different BCP ceramics at the end of 4 weeks. This study indicates that formation of new bone depends on the ceramic content with high HAP-TCP ratio and high dose of rhBMP-2.

Original languageEnglish (US)
Pages (from-to)1643-1651
Number of pages9
JournalBiomaterials
Volume22
Issue number12
DOIs
StatePublished - Jun 15 2001
Externally publishedYes

Fingerprint

Ceramics
Durapatite
Hydroxyapatite
Bone
Phosphates
Proteins
Calcium phosphate
Osteogenesis
Alkaline Phosphatase
Rats
Animals
Bone and Bones
recombinant human bone morphogenetic protein-2
tricalcium phosphate
Tissue
Phosphatases
Connective Tissue
hydroxyapatite-beta tricalcium phosphate
Wistar Rats

Keywords

  • BCP ceramics
  • Bone formation
  • Bone morphogenetic protein
  • Carrier
  • HAP/TCP

ASJC Scopus subject areas

  • Biotechnology
  • Bioengineering
  • Biomedical Engineering

Cite this

Evaluation of ceramics composed of different hydroxyapatite to tricalcium phosphate ratios as carriers for rhBMP-2. / Alam, Imranul; Asahina, Izumi; Ohmamiuda, Kohichi; Takahashi, Kouichiro; Yokota, Shoji; Enomoto, Shoji.

In: Biomaterials, Vol. 22, No. 12, 15.06.2001, p. 1643-1651.

Research output: Contribution to journalArticle

Alam, Imranul ; Asahina, Izumi ; Ohmamiuda, Kohichi ; Takahashi, Kouichiro ; Yokota, Shoji ; Enomoto, Shoji. / Evaluation of ceramics composed of different hydroxyapatite to tricalcium phosphate ratios as carriers for rhBMP-2. In: Biomaterials. 2001 ; Vol. 22, No. 12. pp. 1643-1651.
@article{6370dac2347446bebca9c19afde7adff,
title = "Evaluation of ceramics composed of different hydroxyapatite to tricalcium phosphate ratios as carriers for rhBMP-2",
abstract = "We have investigated pellet-shaped implants prepared from biphasic calcium phosphate (BCP) ceramics with five different ratios of hydroxyapatite (HAP) to beta tricalcium phosphate (β-TCP). The purpose of this study was to evaluate these BCP ceramics as carriers for rhBMP-2. BCP ceramics impregnated with the different doses of recombinant human bone morphogenetic protein 2 (rhBMP-2) (1, 5 and 10μg) were used for the experimental purpose and the ceramics without rhBMP-2 were used as control. The pellets were placed into subcutaneous pockets on the dorsum of 4-week-old male Wistar rats. The animals were sacrificed 2 and 4 weeks after implantation. Bone induction was estimated by alkaline phosphatase (ALP) activity measured at 2 weeks after implantation. Pellets were also examined radiologically, histologically and histomorphometrically. The results showed that all experimental pellets exhibited new bone formation whereas the control pellets produced only fibrous connective tissue. Here, 100{\%} HAP ceramic showed most amount of bone formation, whereas 25{\%} HAP to 75{\%} TCP ceramic produced the bone least in amount among different BCP ceramics at the end of 4 weeks. This study indicates that formation of new bone depends on the ceramic content with high HAP-TCP ratio and high dose of rhBMP-2.",
keywords = "BCP ceramics, Bone formation, Bone morphogenetic protein, Carrier, HAP/TCP",
author = "Imranul Alam and Izumi Asahina and Kohichi Ohmamiuda and Kouichiro Takahashi and Shoji Yokota and Shoji Enomoto",
year = "2001",
month = "6",
day = "15",
doi = "10.1016/S0142-9612(00)00322-7",
language = "English (US)",
volume = "22",
pages = "1643--1651",
journal = "Biomaterials",
issn = "0142-9612",
publisher = "Elsevier BV",
number = "12",

}

TY - JOUR

T1 - Evaluation of ceramics composed of different hydroxyapatite to tricalcium phosphate ratios as carriers for rhBMP-2

AU - Alam, Imranul

AU - Asahina, Izumi

AU - Ohmamiuda, Kohichi

AU - Takahashi, Kouichiro

AU - Yokota, Shoji

AU - Enomoto, Shoji

PY - 2001/6/15

Y1 - 2001/6/15

N2 - We have investigated pellet-shaped implants prepared from biphasic calcium phosphate (BCP) ceramics with five different ratios of hydroxyapatite (HAP) to beta tricalcium phosphate (β-TCP). The purpose of this study was to evaluate these BCP ceramics as carriers for rhBMP-2. BCP ceramics impregnated with the different doses of recombinant human bone morphogenetic protein 2 (rhBMP-2) (1, 5 and 10μg) were used for the experimental purpose and the ceramics without rhBMP-2 were used as control. The pellets were placed into subcutaneous pockets on the dorsum of 4-week-old male Wistar rats. The animals were sacrificed 2 and 4 weeks after implantation. Bone induction was estimated by alkaline phosphatase (ALP) activity measured at 2 weeks after implantation. Pellets were also examined radiologically, histologically and histomorphometrically. The results showed that all experimental pellets exhibited new bone formation whereas the control pellets produced only fibrous connective tissue. Here, 100% HAP ceramic showed most amount of bone formation, whereas 25% HAP to 75% TCP ceramic produced the bone least in amount among different BCP ceramics at the end of 4 weeks. This study indicates that formation of new bone depends on the ceramic content with high HAP-TCP ratio and high dose of rhBMP-2.

AB - We have investigated pellet-shaped implants prepared from biphasic calcium phosphate (BCP) ceramics with five different ratios of hydroxyapatite (HAP) to beta tricalcium phosphate (β-TCP). The purpose of this study was to evaluate these BCP ceramics as carriers for rhBMP-2. BCP ceramics impregnated with the different doses of recombinant human bone morphogenetic protein 2 (rhBMP-2) (1, 5 and 10μg) were used for the experimental purpose and the ceramics without rhBMP-2 were used as control. The pellets were placed into subcutaneous pockets on the dorsum of 4-week-old male Wistar rats. The animals were sacrificed 2 and 4 weeks after implantation. Bone induction was estimated by alkaline phosphatase (ALP) activity measured at 2 weeks after implantation. Pellets were also examined radiologically, histologically and histomorphometrically. The results showed that all experimental pellets exhibited new bone formation whereas the control pellets produced only fibrous connective tissue. Here, 100% HAP ceramic showed most amount of bone formation, whereas 25% HAP to 75% TCP ceramic produced the bone least in amount among different BCP ceramics at the end of 4 weeks. This study indicates that formation of new bone depends on the ceramic content with high HAP-TCP ratio and high dose of rhBMP-2.

KW - BCP ceramics

KW - Bone formation

KW - Bone morphogenetic protein

KW - Carrier

KW - HAP/TCP

UR - http://www.scopus.com/inward/record.url?scp=0035876414&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035876414&partnerID=8YFLogxK

U2 - 10.1016/S0142-9612(00)00322-7

DO - 10.1016/S0142-9612(00)00322-7

M3 - Article

C2 - 11374466

AN - SCOPUS:0035876414

VL - 22

SP - 1643

EP - 1651

JO - Biomaterials

JF - Biomaterials

SN - 0142-9612

IS - 12

ER -